Entera Bio Ltd. (ENTX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 4, 2025 | CORRESP | Neutral/Informational | Moderate | Entera Bio Ltd. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3, which was filed on May 30, 2025. The comp… | Read Filing EDGAR |
| Jun. 4, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Entera Bio Ltd. that it will not review the company's registration statement filed on May 30, 2025. This indicates that the SEC is not taking action on… | Read Filing EDGAR |
| May. 23, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Entera Bio Ltd.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes the company's responsibility for the acc… | Read Filing EDGAR |
| May. 20, 2025 | CORRESP | Neutral/Informational | Moderate | Entera Bio Ltd. has submitted a response to the SEC's comment letter regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested more detailed disclos… | Read Filing EDGAR |
| May. 6, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has issued a comment letter to Entera Bio Ltd. regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC has specifically requested more detailed disc… | Read Filing EDGAR |